Clinical outcomes of sofosbuvir/velpatasvir in hepatitis C virus-infected patients with end-stage renal disease on maintenance hemodialysis

Clinical outcomes of sofosbuvir/velpatasvir in hepatitis C virus-infected patients with end-stage renal disease on maintenance hemodialysis

Objective To evaluate the safety and efficacy of 12-week sofosbuvir/velpatasvir (SOF/VEL) in chronic hepatitis C (CHC) patients with end-stage renal disease (ESRD) on maintenance hemodialysis (MHD) in a real-world setting. Methods From October 10, 2020 to January 28, 2021, 18 CHC patients received f...

Full description

Bibliographic Details
Main Authors: Li-xia Yu, Jian-ming Ye, Xiao-ya Yin, Qi-feng Liu, Qiang Sun
Format: Article
Language:zho
Published: Editorial Department of Journal of Clinical Nephrology 2023-10-01
Series:Linchuang shenzangbing zazhi
Subjects:
hemodialysis
hepatitis c
end-stage renal disease
Online Access:http://www.lcszb.com/cn/article/doi/10.3969/j.issn.1671-2390.2023.10.008

Internet

http://www.lcszb.com/cn/article/doi/10.3969/j.issn.1671-2390.2023.10.008

Similar Items